CIBC Asset Management’s Mersana Therapeutics MRSN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-19,067
| Closed | -$1.96M | – | 1108 |
|
|
2023
Q1 | $1.96M | Sell |
19,067
-3,604
| -16% | -$370K | 0.01% | 557 |
|
|
2022
Q4 | $3.32M | Buy |
+22,671
| New | +$3.32M | 0.01% | 434 |
|
|
2022
Q2 | – | Sell |
-42,240
| Closed | -$4.21M | – | 1399 |
|
|
2022
Q1 | $4.21M | Hold |
42,240
| – | – | 0.01% | 389 |
|
|
2021
Q4 | $6.57M | Sell |
42,240
-112
| -0.3% | -$17.4K | 0.02% | 333 |
|
|
2021
Q3 | $9.98M | Buy |
42,352
+12
| +0% | +$2.83K | 0.04% | 234 |
|
|
2021
Q2 | $14.4M | Buy |
42,340
+29,235
| +223% | +$9.93M | 0.06% | 183 |
|
|
2021
Q1 | $5.3M | Buy |
+13,105
| New | +$5.3M | 0.02% | 317 |
|